Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs.
We’ve also sprinkled in some of the largest ADRs from countries that did not make the market cap cut.
These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.
It’s got all the big names and more--but only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.
The beauty of these scans is really in their simplicity.
We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.
Based on the market environment, we can also flip the scan on its head and filter for weakness.
Let’s dive in and take a look at some of the most important stocks from around the world.
From the desk of Steven Strazza @Sstrazza and Ian Culley @Ianculley
Don’t fight trends. It never ends well.
Learning to go with the flow often comes with age and experience. Lucky for us, we have plenty of both at All Star Charts as the current cycle isn’t our first rodeo.
We’ve been pounding the table on the energy trade, gracefully accepting all of this inflation and the outrageous prices at the pump.
What can we do about it?
We can own the strongest commodities that continue to benefit from this inflationary environment. It’s really that simple.
Cathie Wood’s infamous ARK Investment Management is on our list today, as it just added more than 1 million shares of biotech stock Twist Bioscience $TWST.
The latest 13G reports an ownership interest of more than 11% in the synthetic DNA specialist.
From the desk of Steven Strazza @Sstrazza and Ian Culley @Ianculley
The Japanese yen continues to be front and center, as the safe-haven currency can't seem to find its footing.
In a market where risk assets are struggling to catch any sort of sustained bid, finding investment opportunities in yen has been a great strategy. It continues to work.
Aside from providing a stellar trading opportunity, the current intermarket relationship between this forex cross and the bond market may reveal the near-term direction of the US 10-year yield.
Let’s take a look.
Here’s an overlay chart of the USD/JPY pair and the US 10-year yield with a 26-day correlation study in the lower pane:
As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach. It's really been working for us!
One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).
Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.
But the scan doesn't just end there.
We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.
Phillip Frost, the healthcare industry veteran and CEO of OPKO Health $OPK, is on our list again as he accumulates more shares in the pharmaceutical and diagnostics company.
Yesterday, he revealed an additional purchase of roughly $279,226 worth of his own company's stock in a Form 4.
From the desk of Steven Strazza @Sstrazza and Ian Culley @IanCulley
The Japanese yen continues to slide.
In early April, we highlighted the multi-year base in the USD/JPY cross. We were anticipating a significant breakout based on the broad weakness in the yen.
Even gold, one of the worst performing assets, looked strong denominated in yen.
Not long after the post, we got the breakout we expected. And, two months later, the USD/JPY is kicking off its next leg higher, printing fresh 20-year highs.
Let's take it a step further and outline some trade setups in other currencies denominated in yen.
Remember, everything and anything seems to work priced in yen these days.
First, a quick revisit of the USD/JPY chart we shared in April. Here’s the updated version:
Late last week, Speaker of the House Nancy Pelosi reported the purchase of a variety of deep in-the-money call options in Apple $AAPL and Microsoft $MSFT.
The contracts expire in March and June of next year.
Over the past few years, Pelosi has made some very profitable trades using in-the-money calls in names such as Tesla $TSLA and Nvidia $NVDA.
We’ve had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.
For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.
That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.
We expanded our universe to include some mid-caps.
To make the cut for our Minor Leaguers list, a company must have a market cap between $1 and $4B.
This is one of our favorite bottom-up scans: Follow the Flow.
In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.
We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.
Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.
We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.
